(Q48192310)
Statements
1 reference
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. (English)
1 reference
Halldin C
1 reference
Nyberg S
1 reference
Eriksson B
1 reference
Oxenstierna G
1 reference
Farde L
1 reference
1 June 1999
1 reference
156
1 reference
6
1 reference
869-875
1 reference
Identifiers
1 reference
1 reference